{
    "code": "01020060",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01020060",
    "time": "2020-02-25 02:55:24",
    "許可證字號": "衛署藥製字第020060號",
    "註銷狀態": "已註銷",
    "註銷日期": "77\/07\/19",
    "註銷理由": "安用科更新資料",
    "製造許可登錄編號": "",
    "有效日期": "75\/12\/28",
    "發證日期": "68\/12\/28",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102006006",
    "中文品名": "立平注射液（每斯克）",
    "英文品名": "STOPAIN INJECTION (N-METHYLSCOPOLAMINE METHYL&quot;SWISS&quot;",
    "適應症": "胃炎、胃、十二指腸潰瘍等所引起之痙攣性疼痛、以及消化管泌尿器官檢查時之前處置",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "METHSCOPOLAMINE METHYLSULFATE",
    "限制項目": "01國　產",
    "申請商名稱": "1304820200  瑞士藥廠股份有限公司",
    "申請商地址": "台南縣永康鄉埔園村四維街１６４號",
    "主製造廠": [
        {
            "製造廠名稱": "1304820300  瑞士藥廠股份有限公司",
            "製造廠廠址": "台南縣永康市四維街１６４號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208003310",
            "成分名稱": "METHSCOPOLAMINE METHYLSULFATE",
            "含量描述": "0.6",
            "含量": "0.6000000000",
            "單位": "MG"
        }
    ]
}